P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans
U.I. Schwarz1, T. Gramatté2, J. Krappweis1, R. Oertel1, W. Kirch1
1 Institute of Clinical Pharmacology, Faculty of Medicine, University of Technology, and 2 APOGEPHA Arzneimittel GmbH, Dresden, Germany
| Shopping Overview | ||||
| Type | Qtty | Discount | VAT | Price |
| Your basket is empty | ||||
| View Cart | ||||